MICHAEL VOLK to Liver Neoplasms
This is a "connection" page, showing publications MICHAEL VOLK has written about Liver Neoplasms.
Connection Strength
0.808
-
Improving screening for hepatocellular carcinoma by incorporating data on levels of a-fetoprotein, over time. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):437-40.
Score: 0.127
-
Quality improvement measures lead to higher surveillance rates for hepatocellular carcinoma in patients with cirrhosis. Dig Dis Sci. 2013 Apr; 58(4):1157-60.
Score: 0.126
-
Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology. 2008 May; 134(5):1612-4.
Score: 0.093
-
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 07; 76(1):251-274.
Score: 0.060
-
Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology. 2022 06; 75(6):1471-1479.
Score: 0.060
-
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 05; 75(5):1289-1299.
Score: 0.060
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
Score: 0.050
-
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1.
Score: 0.049
-
Estimation of Liver Transplant Related Survival Benefit: the Devil Is in The Details. Gastroenterology. 2016 Feb; 150(2):534-5.
Score: 0.039
-
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev. 2012 May; 21(5):793-9.
Score: 0.030
-
Patient involvement in healthcare is associated with higher rates of surveillance for hepatocellular carcinoma. J Clin Gastroenterol. 2011 Sep; 45(8):727-32.
Score: 0.029
-
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc. 2010 May; 42(4):1194-6.
Score: 0.027
-
The survival benefit of liver transplantation in hepatocellular carcinoma patients. Dig Liver Dis. 2010 Sep; 42(9):642-9.
Score: 0.026
-
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009 Jul; 30(1):37-47.
Score: 0.025
-
A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. Clin Gastroenterol Hepatol. 2010 Mar; 8(3):280-8, 288.e1.
Score: 0.006